Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
87,501
-284
-0.3% -$7.43K 0.35% 71
2026
Q1
$2.47M Sell
87,785
-1,473
-2% -$39.2K 0.45% 66
2025
Q4
$2.22M Sell
89,258
-3,994
-4% -$101K 0.42% 69
2025
Q3
$2.38M Sell
93,252
-402
-0.4% -$9.92K 0.45% 65
2025
Q2
$2.27M Sell
93,654
-1,602
-2% -$37.4K 0.45% 68
2025
Q1
$2.41M Buy
95,256
+279
+0.3% +$7.3K 0.51% 61
2024
Q4
$2.52M Sell
94,977
-446
-0.5% -$12.1K 0.52% 62
2024
Q3
$2.76M Sell
95,423
-447
-0.5% -$13K 0.57% 58
2024
Q2
$2.68M Buy
95,870
+17,956
+23% +$494K 0.59% 58
2024
Q1
$2.16M Sell
77,914
-22,370
-22% -$621K 0.48% 71
2023
Q4
$2.89M Sell
100,284
-80,531
-45% -$2.43M 0.69% 53
2023
Q3
$6M Sell
180,815
-2,163
-1% -$76.5K 1.56% 20
2023
Q2
$6.71M Sell
182,978
-10,675
-6% -$416K 1.68% 16
2023
Q1
$7.9M Sell
193,653
-7,148
-4% -$309K 1.98% 13
2022
Q4
$10.3M Buy
200,801
+4,628
+2% +$222K 2.58% 10
2022
Q3
$8.58M Sell
196,173
-4,020
-2% -$195K 2.44% 7
2022
Q2
$10.5M Buy
200,193
+1,232
+0.6% +$62.8K 2.78% 6
2022
Q1
$10.3M Sell
198,961
-5,760
-3% -$299K 2.39% 8
2021
Q4
$12.1M Buy
204,721
+16,254
+9% +$805K 2.85% 7
2021
Q3
$8.11M Buy
188,467
+1,971
+1% +$87.3K 2.27% 9
2021
Q2
$7.3M Buy
186,496
+979
+0.5% +$38.1K 2.05% 11
2021
Q1
$6.72M Buy
185,517
+15,373
+9% +$546K 2.02% 13
2020
Q4
$6.26M Buy
170,144
+244
+0.1% +$8.95K 2.07% 13
2020
Q3
$5.92M Buy
169,900
+23,250
+16% +$815K 2.29% 11
2020
Q2
$4.55M Sell
146,650
-17,694
-11% -$601K 1.98% 16
2020
Q1
$5.09M Buy
164,344
+6,230
+4% +$212K 2.39% 10
2019
Q4
$5.88M Buy
158,114
+4,342
+3% +$155K 2.09% 11
2019
Q3
$5.24M Buy
153,772
+21,908
+17% +$797K 1.99% 16
2019
Q2
$5.42M Sell
131,864
-219
-0.2% -$8.7K 2.41% 13
2019
Q1
$5.32M Buy
132,083
+1,160
+0.9% +$46.5K 2.44% 11
2018
Q4
$5.42M Sell
130,923
-2,485
-2% -$103K 2.74% 9
2018
Q3
$5.58M Sell
133,408
-795
-0.6% -$30.6K 2.49% 10
2018
Q2
$4.62M Sell
134,203
-258
-0.2% -$8.82K 2.21% 18
2018
Q1
$4.53M Sell
134,461
-2,650
-2% -$91.1K 2.2% 17
2017
Q4
$4.71M Buy
137,111
+2,106
+2% +$71.8K 2.12% 21
2017
Q3
$4.57M Sell
135,005
-1,483
-1% -$47.7K 2.15% 21
2017
Q2
$4.35M Sell
136,488
-4,130
-3% -$130K 2.08% 21
2017
Q1
$4.56M Buy
140,618
+6,613
+5% +$209K 2.24% 19
2016
Q4
$4.13M Buy
134,005
+4,371
+3% +$133K 2.12% 22
2016
Q3
$4.17M Buy
129,634
+2,356
+2% +$78.8K 2.23% 21
2016
Q2
$4.25M Buy
127,278
+2,988
+2% +$95.4K 2.3% 14
2016
Q1
$3.5M Buy
124,290
+2,496
+2% +$71.3K 1.97% 23
2015
Q4
$3.73M Buy
121,794
+4,137
+4% +$130K 2.21% 22
2015
Q3
$3.51M Buy
117,657
+7
+0% +$224 2.4% 19
2015
Q2
$3.74M Buy
117,650
+459
+0.4% +$15K 2.36% 16
2015
Q1
$3.87M Buy
117,191
+775
+0.7% +$24.6K 2.46% 16
2014
Q4
$3.44M Sell
116,416
-1,227
-1% -$35.2K 2.17% 22
2014
Q3
$3.3M Sell
117,643
-2,207
-2% -$61.9K 2.2% 22
2014
Q2
$3.38M Buy
119,850
+1,538
+1% +$43.8K 2.28% 18
2014
Q1
$3.6M Buy
118,312
+11,325
+11% +$338K 2.57% 9
2013
Q4
$3.11M Buy
106,987
+2,191
+2% +$63.8K 2.28% 17
2013
Q3
$2.86M Buy
104,796
+6,247
+6% +$170K 2.24% 15
2013
Q2
$2.62M Buy
+98,549
New +$2.72M 2.16% 16

Other funds holding PFE

Iowa State Bank's PFE Position: Q2 2026 in Review

Iowa State Bank reduced its Pfizer (PFE) stake by 0.32% in Q2 2026, selling an estimated $7.43K and leaving 87,501 shares worth $2.11M. The position accounts for 0.35% of the portfolio, ranked #71.

Iowa State Bank first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.1M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Iowa State Bank held 87,501 shares of Pfizer worth $2.11M as of Q2 2026.
  • Iowa State Bank sold 284 Pfizer shares in Q2 2026, an estimated $7.43K.
  • Pfizer made up 0.35% of Iowa State Bank's portfolio in Q2 2026, its #71 holding.
  • Iowa State Bank first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Iowa State Bank's Pfizer position peaked at $12.1M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Iowa State Bank's 13F filing for Q2 2026, filed 28 Jul 2026.